InvestorsHub Logo
Post# of 251928
Next 10
Followers 5
Posts 277
Boards Moderated 0
Alias Born 05/29/2011

Re: Titan V post# 209613

Saturday, 03/04/2017 9:38:59 AM

Saturday, March 04, 2017 9:38:59 AM

Post# of 251928
Would be competitors for PD-1 refractory melanoma are:

Idera (IDRA) IMO-2125 plus ipi or pembro
Dynavax (DVAX) SD-101 + pembro
Checkpoint CMP-001 + pembro

All three combo trials will have data updates at AACR 1st week in April, DVAX is a late-breaker.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.